Publications
Clinical consequences of generic warfarin substitution: an ecological study
Paterson JM, Mamdani M, Juurlink DN, Naglie G, Laupacis A, Stukel TA. JAMA. 2006; 296(16):1969-72.
Case selection for statins was similar in two Canadian provinces: BC and Ontario
Paterson JM, Carney G, Anderson GM, Bassett K, Naglie G, Laupacis A; BC-Ontario Pharmacosurveillance for Decision-making Collaborative. J Clin Epidemiol. 2007; 60(1):73-8. Epub 2006 Sep 7.
Hospital volume and mortality for mechanical ventilation of medical and surgical patients: a population-based analysis using administrative data
Needham DM, Bronskill SE, Rothwell DM, Sibbald WJ, Pronovost PJ, Laupacis A, Stukel TA. Crit Care Med. 2006; 34(9):2349-54.
Using pharmacoepidemiology to inform drug coverage policy: initial lessons from a two-province collaborative
Paterson JM, Laupacis A, Bassett K, Anderson GM; BC-Ontario Pharmacosurveillance for Decision-Making Collaborative. Health Aff. 2006; 25(5):1436-43.
Use of vascular risk-modifying medications for diabetic patients differs between physician specialties
Shah BR, Hux JE, Laupacis A, Zinman B, Booth GL. Diabet Med. 2006; 23(10):1117-23.
Warfarin prescribing in atrial fibrillation: the impact of physician, patient and hospital characteristics
Choudhry NK, Soumerai SB, Normand SL, Ross-Degnan D, Laupacis A, Anderson GM. Am J Med. 2006; 119(7):607-15.
Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling study
Manuel DG, Kwong K, Tanuseputro P, Lim J, Mustard CA, Anderson GM, Ardal S, Alter DA, Laupacis A. BMJ. 2006; 332(7555):1419. Epub 2006 May 31.
Persistence with bisphosphonate therapy in older people
Melo M, Qiu F, Sykora K, Juurlink D, Laupacis A, Mamdani M. J Am Geriatr Soc. 2006; 54(6):1015-6.